228 related articles for article (PubMed ID: 18463539)
1. Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells.
Capobianco A; Manfredi AA; Monno A; Rovere-Querini P; Rugarli C
J Immunother; 2008 Jun; 31(5):458-65. PubMed ID: 18463539
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor effect of dendritic cell based immunotherapy after intratumoral injection of radionuclide Ho-166 against B16 melanoma.
Lee TH; Cho YH; Lee JD; Yang WI; Shin JL; Lee MG
Immunol Lett; 2006 Jul; 106(1):19-26. PubMed ID: 16647143
[TBL] [Abstract][Full Text] [Related]
3. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.
Hu J; Yuan X; Belladonna ML; Ong JM; Wachsmann-Hogiu S; Farkas DL; Black KL; Yu JS
Cancer Res; 2006 Sep; 66(17):8887-96. PubMed ID: 16951206
[TBL] [Abstract][Full Text] [Related]
4. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
Fujii S; Shimizu K; Hemmi H; Steinman RM
Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
[TBL] [Abstract][Full Text] [Related]
5. A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: efficient maturation of DCs by co-culture with LAK cells in vitro.
Yano Y; Ueda Y; Itoh T; Fuji N; Okugawa K; Naito K; Imura K; Kohara J; Hayashi T; Nakane K; Matsuura Y; Kawai K; Yamagishi H
Oncol Rep; 2006 Jul; 16(1):147-52. PubMed ID: 16786138
[TBL] [Abstract][Full Text] [Related]
6. [Non-specific killer cells in tumor immune response].
Kumagai K
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):726-33. PubMed ID: 3985642
[TBL] [Abstract][Full Text] [Related]
7. Human natural killer cells: a comprehensive review.
Sinkovics JG; Horvath JC
Int J Oncol; 2005 Jul; 27(1):5-47. PubMed ID: 15942642
[TBL] [Abstract][Full Text] [Related]
8. Eosinophils induce DC maturation, regulating immunity.
Lotfi R; Lotze MT
J Leukoc Biol; 2008 Mar; 83(3):456-60. PubMed ID: 17991762
[TBL] [Abstract][Full Text] [Related]
9. The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells.
Fujisawa Y; Nabekura T; Nakao T; Nakamura Y; Takahashi T; Kawachi Y; Otsuka F; Onodera M
Exp Dermatol; 2009 Apr; 18(4):396-403. PubMed ID: 19054057
[TBL] [Abstract][Full Text] [Related]
10. Melanoma cells interfere with the interaction of dendritic cells with NK/LAK cells.
Capobianco A; Rovere-Querini P; Rugarli C; Manfredi AA
Int J Cancer; 2006 Dec; 119(12):2861-9. PubMed ID: 16998790
[TBL] [Abstract][Full Text] [Related]
11. DC therapy induces long-term NK reactivity to tumors via host DC.
Shimizu K; Fujii S
Eur J Immunol; 2009 Feb; 39(2):457-68. PubMed ID: 19180466
[TBL] [Abstract][Full Text] [Related]
12. Helper role of NK cells during the induction of anticancer responses by dendritic cells.
Kalinski P; Giermasz A; Nakamura Y; Basse P; Storkus WJ; Kirkwood JM; Mailliard RB
Mol Immunol; 2005 Feb; 42(4):535-9. PubMed ID: 15607810
[TBL] [Abstract][Full Text] [Related]
13. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
Fujii S
Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
[TBL] [Abstract][Full Text] [Related]
14. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
[TBL] [Abstract][Full Text] [Related]
15. Increased survival and decreased tumor size due to intratumoral injection of ethanol followed by administration of immature dendritic cells.
Kumagi T; Akbar SM; Horiike N; Onji M
Int J Oncol; 2003 Oct; 23(4):949-55. PubMed ID: 12963973
[TBL] [Abstract][Full Text] [Related]
16. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus.
Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y
J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206
[TBL] [Abstract][Full Text] [Related]
17. Immune responsiveness in a mouse model of combined adoptive immunotherapy with NK and dendritic cells.
Cui F; Ji J; Lv H; Qu D; Yu C; Yang Y; Xu Y
J Cancer Res Ther; 2013 Nov; 9 Suppl():S162-8. PubMed ID: 24516054
[TBL] [Abstract][Full Text] [Related]
18. The 'kiss of death' by dendritic cells to cancer cells.
Chan CW; Housseau F
Cell Death Differ; 2008 Jan; 15(1):58-69. PubMed ID: 17948029
[TBL] [Abstract][Full Text] [Related]
19. Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously.
Shojaeian J; Jeddi-Tehrani M; Dokouhaki P; Mahmoudi AR; Ghods R; Bozorgmehr M; Nikoo S; Bayat AA; Akhondi MM; Ostadkarampour M; Rezania S; Zarnani AH
J Immunother; 2009 May; 32(4):325-32. PubMed ID: 19342973
[TBL] [Abstract][Full Text] [Related]
20. Combined radiation therapy and dendritic cell vaccine for treating solid tumors with liver micro-metastasis.
Chen Z; Xia D; Bi X; Saxena A; Sidhu N; El-Gayed A; Xiang J
J Gene Med; 2005 Apr; 7(4):506-17. PubMed ID: 15580588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
